Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging

Sha Lou, Benjamin Balluff, Arjen H. G. Cleven, Judith V. M. G. Bovee, Liam A. McDonnell*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)376-383
Number of pages8
JournalJournal of the American Society for Mass Spectrometry
Volume28
Issue number2
DOIs
Publication statusPublished - Feb 2017

Keywords

  • Metabolites
  • Prognosis
  • Biomarker discovery
  • MALDI-MSI
  • High grade sarcoma
  • Leiomyosarcoma
  • Myxofibrosarcoma
  • Osteosarcoma
  • Undifferentiated pleomorphic sarcoma
  • Soft tissue sarcoma
  • THERAPEUTIC TARGETS
  • CURRENT STATE
  • CANCER-CELLS
  • MS
  • METABOLOMICS
  • VISUALIZATION
  • DIAGNOSIS
  • HISTOLOGY
  • TUMORS
  • GRADE

Cite this